The ability of new absorbable bone wax in stopping bone bleeding during craniotomy or craniectomy will be evaluated together with the handling properties.
Conditions
Interventions
Craniotomy or craniectomy is carried out. New absorbable bone wax would be applied to stop bleeding of the bone at the cuttinf edges. Its effciency will be evaluated.
Experimental Device
craniotomy or craniectomy
Sponsors
National Science and Technology Development Agency
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: • Patients who undergo general brain surgery. • Patients who undergo craniotomy or craniectomy or skull surgery which create burr hole. • Patients who have clean wound.
Exclusion criteria
Exclusion criteria: • Patients who have skull infection or osteomyelitis or inflammation • Patients who have blood chemistry which indicated the inflammation i.e higher than normal values of WBC, ESR. • Patients who have opened wound. • Patients who have renal insufficiency or renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemostasis performance of absorable bone wax Intraoperative Observation | — |
Secondary
| Measure | Time frame |
|---|---|
| Handling properties of absorbable bone wax Intraoperative Manually by hand | — |
Countries
Thaiand
Contacts
Public ContactPataravit Rukskul
hospital medical school affiliations
Outcome results
None listed